Overview
Intravenous Dexmedetomidine For The Quaity Of Emergence From General Anesthesia
Status:
Completed
Completed
Trial end date:
2015-09-01
2015-09-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
In a prospective randomized clinical trial involving adult patients undergoing elective surgery under general anesthesia, the investigators will enroll 216 patients, and evaluate 3 doses of prophylactic dexmedetomidine as a means to reduce postoperative shivering and quality of emergence from anesthesia versus placebo.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
American University of Beirut Medical CenterTreatments:
Anesthetics
Dexmedetomidine
Criteria
Inclusion Criteria:- 18-80 year-old
- ASA class I, II, and III
- patients undergoing elective surgery under general anesthesia with an estimated time
of 1-3 h
Exclusion Criteria:
- duration of surgery less than 1h or more than 3 h
- allergy to dexmedetomidine
- vasoactive antidepressant or analgesics
- obesity (BMI>30)
- fever
- pregnancy